54 Biggest Movers From Yesterday
Gainers
Digital World Acquisition Corp. (NASDAQ: DWAC) shares climbed 356.8% to close at $45.50 on Thursday following an announcement the company will merge with Trump Media & Technology Group.
Mizuho Downgrades Kadmon Holdings to Neutral, Lowers Price Target to $9.5
Mizuho analyst Mara Goldstein downgrades Kadmon Holdings (NASDAQ:KDMN) from Buy to Neutral and lowers the price target from $13 to $9.5.
The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs
Biotech stocks retreated in the holiday-shortened week ending Sept. 10, reversing course from the previous week.
10 Biggest Price Target Changes For Thursday
Telsey Advisory Group lifted the price target on Lululemon Athletica Inc. (NASDAQ: LULU) from $460 to $485. Lululemon shares surged 13.9% to $433.58 in pre-market trading.
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi’s Pemphigus Trial Disappointment, Humanigen’s COVID-19 Drug Denied Emergency Use Authorization
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 8)
Jefferies Downgrades Kadmon Holdings to Hold, Lowers Price Target to $9.5
Jefferies downgrades Kadmon Holdings (NASDAQ:KDMN) from Buy to Hold and lowers the price target from $10 to $9.5.
54 Biggest Movers From Yesterday
Gainers
eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) shares jumped 111.8% to settle at $27.17 on Wednesday after jumping 50% on Tuesday.
Mid-Afternoon Market Update: Kadmon Surges Following Acquisition News; UiPath Shares Drop
Toward the end of trading Wednesday, the Dow traded down 0.24% to 35,015.62 while the NASDAQ fell 0.61% to 15,280.10. The S&P also fell, dropping 0.20% to 4,510.78.